Back to Signals

Signal · Clinical Psychology

Brief GP-delivered psychological intervention improves quality of life a year after ICU discharge, trial finds

A secondary analysis of a randomised trial finds a brief GP-delivered intervention for ICU survivors with PTSD symptoms produced a delayed but clinically meaningful quality-of-life improvement at 12 months.

1 min read Primary Study NEW

A secondary analysis of the PICTURE randomised controlled trial followed 319 adult intensive care unit (ICU) survivors with at least moderate post-traumatic stress disorder (PTSD) symptoms, randomised to a brief general-practitioner-delivered narrative exposure intervention or enhanced usual care [Primary Study]. Longitudinal mixed-effects modelling found a transient improvement in health-related quality of life at 6 months, followed by a delayed but clinically meaningful improvement in the EQ-5D-5L index at 12 months. Around a quarter of the 12-month effect was statistically mediated by reduction in PTSD symptoms at 6 months.

This is a secondary, mediation-focused analysis of an existing trial rather than a new primary outcome report, and the trial population was recruited through German primary care, not tested in an NHS setting — the finding is evidence of concept from a comparable health system rather than a directly NHS-validated result.

The result is relevant wherever ICU survivors are discharged into primary care and specialist trauma therapy capacity is limited: it offers evidence that a brief, primary-care-deliverable intervention can produce meaningful longer-term quality-of-life gains, even though the benefit builds slowly and is only partly explained by symptom reduction — meaning services assessing effectiveness shortly after discharge may not see the full effect.

Sources

  1. Kosilek RP, Schröder N, Sanftenberg L, et al. Effects of a brief primary care intervention for post-traumatic stress disorder symptoms after critical illness on health-related quality of life: a secondary analysis of the PICTURE randomised controlled trial. European Journal of General Practice. 2026;32(1):2702686. doi:10.1080/13814788.2026.2702686 PMID 42480006